Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of hepatitis B and delta coinfection in Israel.
Shirazi R, Ram D, Rakovsky A, Bucris E, Gozlan Y, Lustig Y, Shaked-Mishan P, Picard O, Shemer-Avni Y, Ben-Zvi H, Halutz O, Lurie Y, Veizman E, Carlebach M, Braun M, Naftaly MC, Shlomai A, Safadi R, Mendelson E, Sklan EH, Ben-Ari Z, Mor O. Shirazi R, et al. Among authors: picard o. BMC Infect Dis. 2018 Feb 27;18(1):97. doi: 10.1186/s12879-018-3008-x. BMC Infect Dis. 2018. PMID: 29486716 Free PMC article.
Propagation of EBV-driven Lymphomatous Transformation of Peripheral Blood B Cells by Immunomodulators and Biologics Used in the Treatment of Inflammatory Bowel Disease.
Levhar N, Ungar B, Kopylov U, Fudim E, Yavzori M, Picard O, Amariglio N, Chowers Y, Shemer-Avni Y, Mao R, Chen MH, Ye Z, Eliakim R, Ben-Horin S. Levhar N, et al. Among authors: picard o. Inflamm Bowel Dis. 2020 Aug 20;26(9):1330-1339. doi: 10.1093/ibd/izaa065. Inflamm Bowel Dis. 2020. PMID: 32322878
Lessons from intensified surveillance of viral hepatitis A, Israel, 2017 and 2018.
Gozlan Y, Bar-Or I, Volnowitz H, Asulin E, Rich R, Anis E, Shemer Y, Szwarcwort Cohen M, Dahary EL, Schreiber L, Goldiner I, Rozenberg O, Picard O, Savion M, Fuchs I, Mendelson E, Mor O. Gozlan Y, et al. Among authors: picard o. Euro Surveill. 2021 Feb;26(6):2000001. doi: 10.2807/1560-7917.ES.2021.26.6.2000001. Euro Surveill. 2021. PMID: 33573709 Free PMC article.
Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases.
Ungar B, Levy I, Yavne Y, Yavzori M, Picard O, Fudim E, Loebstein R, Chowers Y, Eliakim R, Kopylov U, Ben-Horin S. Ungar B, et al. Among authors: picard o. Clin Gastroenterol Hepatol. 2016 Apr;14(4):550-557.e2. doi: 10.1016/j.cgh.2015.10.025. Epub 2015 Oct 29. Clin Gastroenterol Hepatol. 2016. PMID: 26538204
Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Diseases.
Ungar B, Kopylov U, Yavzori M, Fudim E, Picard O, Lahat A, Coscas D, Waterman M, Haj-Natour O, Orbach-Zingboim N, Mao R, Chen M, Chowers Y, Eliakim R, Ben-Horin S. Ungar B, et al. Among authors: picard o. Clin Gastroenterol Hepatol. 2018 May;16(5):697-705.e7. doi: 10.1016/j.cgh.2017.11.050. Epub 2017 Dec 7. Clin Gastroenterol Hepatol. 2018. PMID: 29223444
167 results